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Background: Bipolar disorder is highly recurrent and rates of comorbidity are high. Studies have pointed to anxiety comorbidity as
one factor associated with risk of suicide attempts and poor overall outcome. This study aimed to explore the feasibility and
potential benefits of a new psychological treatment (Mindfulness-based Cognitive Therapy: MBCT) for people with bipolar
disorder focusing on between-episode anxiety and depressive symptoms.
Methods: The study used data from a pilot randomized trial of MBCT for people with bipolar disorder in remission, focusing on
between-episode anxiety and depressive symptoms. Immediate effects of MBCT versus waitlist on levels of anxiety and depression
were compared between unipolar and bipolar participants.
Results: The results suggest that MBCT led to improved immediate outcomes in terms of anxiety which were specific to the bipolar
group. Both bipolar and unipolar participants allocated to MBCT showed reductions in residual depressive symptoms relative to
those allocated to the waitlist condition.
Limitations: Analyses were based on a small sample, limiting power. Additionally the study recruited participants with suicidal
ideation or behaviour so the findings cannot immediately be generalized to individuals without these symptoms.
Conclusions: The study, although preliminary, suggests an immediate effect of MBCT on anxiety and depressive symptoms among
bipolar participants with suicidal ideation or behaviour, and indicates that further research into the use of MBCT with bipolar
patients may be warranted.
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Pharmacological treatment has been the treatment of
choice for patients with bipolar disorder for many years.
However, even with good maintenance medication, 73%
of patients relapse within 5 years (Gitlin et al., 1995).
Poorer overall outcome is associated with a high rate ofse. 
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anxiety disorders, which are present in approximately
64% of bipolar patients (Simon et al., 2005). Therefore,
psychological interventions have assumed increasing
interest as a way of improving mood stability. Cognitive
Behaviour Therapy (CBT) has had the clearest claims to
be a specific intervention based broadly on Beck's ideas
about how cognitions shape mood (Scott and Colom,
2005). However, initially promising findings (Lam
et al., 2003) have not been confirmed in what was
intended to be a definitive trial (Scott et al., 2006).
Recently, our group has been investigating the useful-
ness of a new psychological treatment for patients with a
history of suicidality. Mindfulness-based Cognitive Ther-
apy (MBCT) combines aspects of cognitive therapy with
training in meditation. MBCT teaches people skills that
enable them to become more aware of their thoughts
without judgment, viewing negative (positive and neutral)
thoughts as passing mental events rather than as facts.
MBCT has proven effective in preventing relapse in
recurrent depression (Ma and Teasdale, 2004; Teasdale
et al., 2000). The treatment is closely based on an approach
that is known to be helpful in the treatment of anxiety
disorders (Mindfulness-based Stress Reduction: Miller
et al., 1995), so this study provides an opportunity to
evaluate its impact on between-episode anxiety in bipolar
patients.
Our research has been concerned with the application of
MBCT to those patients who become suicidal when
depressed. Because bipolar disorder carries a high risk of
suicide, we included patients with this diagnosis in a
randomized controlled trial wewere conducting. It has been
estimated that between 10% and 15% of hospitalized
bipolar patients die from suicide (Hawton et al., 2005) and
the risk factors include depression and anxiety comorbidity.
This suggests that therapeutic efforts to target any of these
correlates might have an impact on the illness morbidity
(Leverich et al., 2003) and perhaps mortality.
In summary, this study aimed to explore the
feasibility and potential benefits of MBCT for people
with bipolar disorder, using data collected from a pilot
randomized controlled trial of MBCT for people with a
history of suicidal ideation or behaviour. The study
hypothesis was that MBCT would improve between-
episode anxiety and depressive symptoms.
2. Method
2.1. Sample
The sample was recruited as part of preliminary
randomized controlled trial that aimed to examine theacceptability and mechanisms of action of Mindful-
ness-based Cognitive Therapy (MBCT) delivered to
patients in remission, but with a history of serious
suicidal ideation or behaviour. Participants aged
between 18 and 65 who met inclusion criteria (at
least one prior episode of major depression accompa-
nied by serious suicidal ideation) were recruited from
general practitioners and local psychologists/psychia-
trists and from the community. All participants were
required to meet NIMH criteria for recovery at the time
of participation (no more than one week of minimal
depressive symptoms in the past 8 weeks), and to have
experienced no manic episodes for at least 6 months.
One hundred and twenty eight people who contacted
the group on time and were interested in the study were
screened; only 83 were eligible. A further 15 partici-
pants did not attend their first assessment or withdrew
after the first assessment. The final sample included 68
participants who were randomly allocated (concealed
from trial team) to immediate treatment with MBCT (24
unipolar, 9 bipolar) or to waiting list control condition
(27 unipolar, 8 bipolar). Follow-up data were available
from 21 unipolar and 7 bipolar participants in the MBCT
group and from 20 unipolar and 7 bipolar participants in
the waitlist group.
2.2. Procedure
Participants were interviewed using the Mini Inter-
national Neuropsychiatric Interview MINI (Sheehan
et al., 1998) to establish psychiatric history. Following
this, participants completed a number of other assess-
ment measures. These measures were completed again
at the end of treatment or waitlist; those of relevance to
the current study are described below. Randomization
was concealed by use of sealed envelopes prepared by
an individual outside the research team.
2.3. Questionnaires
2.3.1. Beck Depression Inventory (BDI-II) (Beck et al.,
1996)
The BDI-II is a well established 21-item self report
questionnaire used to measure the severity of depressive
symptoms.
2.3.2. Beck Anxiety Inventory (BAI) (Beck and Steer,
1990)
The BAI is a 21-item self report questionnaire that
measures the common symptoms of anxiety. The scale is
reliable and valid and is able to differentiate anxiety
from depression.
Table 1
Measures of mood
Measures
of mood
Unipolar Bipolar
Control (20) MBCT (14) Control (7) MBCT (7)
Pre Post Pre Post Pre Post Pre Post
BAI 9.3 (6.5) 8.0 (5.8) 10.7 (8.6) 10.7 (10.5) 11.4 (8.5) 20.6 (11.3) 12.7 (12.1) 6.8 (5.7)
BDI 12.8 (10.2) 11.2 (10.8) 15.5 (14.1) 9.5 (13.8) 12.8 (8.1) 15.3 (12.6) 15.8 (14.4) 7.1 (7.7)
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During the trial, both groups of patients were
encouraged to continue to attend outpatient appoint-
ments, receive medication and benefit from any other
services they would otherwise have received. At post-
assessment participants were interviewed about treat-
ment received during their period of involvement with
study. In the control group 4 participants had received
other psychotherapy by visiting their psychiatrists (3
unipolar, 1 bipolar), whilst in the MBCT group 4
participants had done so (2 unipolar, 2 bipolar). None of
the participants reported using non-MBCTmeditation or
yoga for therapeutic purpose during their trial period.
The MBCT classes were led by two experienced
therapists with recognized expertise in the delivery of
cognitive therapy and MBCT. The classes included 12–
15 participants and met weekly for 2 h over a period of
8 weeks, including a full-day of meditation practice
following week 6. Participants were also asked to
complete homework (including daily meditation prac-
tice, observations of thoughts, feelings and bodily
reactions) which was expected to take at least 45 min
per day, 6 days per week. The MBCTapproach has been
described in detail elsewhere (Segal et al., 2002).
3. Results
3.1. Sample characteristics
In these analyses we aimed to explore whether
bipolar patients differed from unipolar patients in their
baseline characteristics. We aimed also to explore
whether bipolar in the MBCT differs from bipolar in
waitlist group. Statistical analysis revealed no signifi-
cant differences in the sample characteristics on most
aspects, including gender, age and current occupation
status.
3.2. Depression (BDI)
There were no main effects of group (Unipolar, Bipo-
lar) or condition (MBCT, waitlist), but there was a maineffect of time, F (1, 41)=6.07, p=.018, and a significant
two-way time×condition interaction, F (1, 41)=8.05,
p=.007. Follow-up Bonferroni-corrected post-hoc com-
parisons indicated that patients receiving MBCT showed
reduced depression at time 2 (Mi-j=−1.29, SE=.34,
pb .001) compared to time 1, while no time difference
was found among patients in the waitlist condition. This
resulted in a significant difference in level of depression
between participants allocated to MBCT and those
allocated to waitlist at time 2 (Mi-j=−1.12, SE=.55,
pb .05), whilst there was no significant difference at time 1.
The three-way time×group×condition interaction was not
significant.
3.3. Anxiety (BAI)
There were no main effects of time, group or condi-
tion on BAI scores. There were also no group× time or
group×condition interactions. However there was a
two-way time×condition interaction, F (1, 41)=5.63,
p=.022; and a three-way time×group×condition inter-
action, F (1, 41)=7.55, p=.009.
Follow-up Bonferroni-corrected post-hoc comparisons
found no difference in BAI level between bipolar patients
in the waitlist and in the MBCT conditions at time 1.
However, those who had receivedMBCT had significantly
lower anxiety at time 2 than those in the waitlist condition
(Mi-j=−1.951, SE= .758, p=.014). Unipolar groups
(MBCT and waitlist conditions) did not differ in BAI
score at either time point. The comparisons also indicated
that whilst bipolar patients receiving MBCT showed no
significant change in BAI level from time 1 to time 2,
bipolar patients in the waitlist condition showed a
significant increase in their scores over time (Mi-j=1.28,
SE=.417, p=.004). No significant difference was found
between time 1 and time 2 among unipolar patients. Means
and standard deviations are shown in Table 1.
4. Discussion
This study reports data from a pilot randomized
controlled trial of MBCT for patients with a history
of suicidal ideation or behaviour (including unipolar
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first to assess the immediate benefits of MBCT for
people with bipolar disorder. The results suggest
significant effects of MBCT in limiting increased
anxiety over time which were specific to the bipolar
group. The effect of MBCT in reducing depression
was observed among all participants attending MBCT
(bipolar and unipolar) and was not specific to either
group.
4.1. BAI measure
Anxiety disorders are highly comorbid with bipolar
disorder and this comorbidity is associated with poor
outcome and suicide risk. Hence anxiety symptoms are
an important, if often neglected, indicator of treatment
outcome (Goodwin and Sachs, 2004). It is thus of great
potential interest in this study that the bipolar patients
who received MBCT had significantly lower anxiety
scores at time 2 compared with the bipolar waitlist
controls. The unipolar group showed no such differen-
tial change in BAI score. This suggests that the
protective effect of MBCT on levels of anxiety was
specific to bipolar patients.
4.2. BDI measure
Depressive symptoms were significantly improved
by MBCT for both unipolar and bipolar patients at time
2, and no differential effect was found for bipolar versus
unipolar patients. The finding that MBCT reduces
residual symptoms of depression is comparable with
the pilot study of Scott et al. (2001) on cognitive
therapy, which found that the bipolar patients who
received cognitive therapy achieved significant reduc-
tions in level of depression as measured by the Internal
State Scale.
Studies from different patient groups have shown
that meditation-based therapy results in immediate
post-treatment improvements in anxiety and depressive
symptoms (Kabat-Zinn et al., 1992) and that this
improvement is maintained over 3 years follow-up
(Miller et al., 1995). Studies also show that patients
with three or more past episodes of unipolar depression
who receive MBCT have lower relapse rates over a 12-
month follow-up than waitlist controls (Ma and Teas-
dale, 2004; Teasdale et al., 2000). The current study
suggests that MBCT improves anxiety and depressive
symptoms in bipolar patients. It clearly suggests that
MBCT may be a trans-diagnostic therapeutic tool,
suitable for bipolar disorder as well as other psychiatric
conditions.5. Limitations
The study suffers from a number of limitations that
restrict the confidence with which conclusions can be
drawn. First, it is preliminary and was designed to
establish feasibility and acceptability. The sample sizes
are small. Moreover, the study was not designed
specifically to demonstrate a difference between bipolar
and unipolar patients and so did not include measures of
manic experience or symptoms. It is possible that some
individuals had experienced subsyndromal manic/hy-
pomanic symptoms during the study period. Further
trials on MBCT in bipolar disorder should use measures
of manic symptoms, or mania-related beliefs (e.g. the
HAPPI: Mansell, 2006).
Secondly, some psychological treatments for bipolar
disorder may work partly through increasing medica-
tion adherence or producing changes in life style that
encourage greater regularity (Bauer, 2002). We cannot
rule out such treatment effects due to non-specific group
factors. However, there is a reason to expect specific
benefits from MBCT in bipolar disorder because it
provides a mood regulation strategy in its own right. It
teaches people to notice mood shifts early and to accept
them rather than strive to avoid them, and thus may help
to prevent the escalation of mood-activated patterns of
unhelpful thinking.
Finally, the study preferentially recruited patients with
a history of suicidal ideation or behaviour as part of their
symptom profile, so we cannot immediately generalize
the findings of this study to those patients who do not
show such symptoms. However, patients who habitually
become suicidal when depressed are often the most
difficult to treat, and create the greatest concern amongst
clinicians. Finding significant changes in important areas
of psychopathology in this sub-group is very promising.
However, future research will need to include a follow-up
to confirm whether these short-term effects will persist,
and be related to a less severe illness course.
In summary, suicidal bipolar and unipolar patients
show reductions in depressive symptoms following
treatment with MBCT. Intriguingly, the largest effects –
on anxiety – were confined to the bipolar group. These
initial results are only preliminary but are sufficient to
suggest that further investigation of MBCT for bipolar
disorder is warranted.
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